ANDREA CRAWFORD: Open Payments
NPI 1376042069 · FARMINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 24 payments from 5 companies in 2025. Trend: 2023 $703 · 2024 $216 · 2025 $833
Food & beverage: $622Education: $210
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $359 |
| Alkermes, Inc. | 14 | $352 |
| ACADIA Pharmaceuticals Inc | 1 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $35 |
Products named: ARISTADA, AUSTEDO XR, LYBALVI, UZEDY, NUPLAZID, REXULTI, VRAYLAR.
Industry payments across MO — which companies pay providers there.
